To further determine whether the regulation of GABPA binding capacity by Sp1 depends on the TERT promoter mutations, we knocked down Sp1 in gastric cancer cell line AGS and colon cancer cell line RKO carrying BRAFV600E mutation and wild-type TERT promoter. This evidence concerns the gene TERT and malignant colon neoplasm.